Immunophenotypic data, available for 202 of the 210 patients, showed that all cases of leukemia were CD19+, 196/202 were CD5+, 188/202 were CD20+ [61/188 expressed (+) and 127/188 expressed (++)] and 200/202 were CD23+. Here, FCER2 is linked to leukemia.